ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.053,68
0,70%
Dow Jones
38.160,96
0,68%
Euro vs US Dollar
1,07164
-0,01%
Bitcoin
59.248,70
1,74%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Mesa Laboratories Inc (MLAB)

  7. Mesa Laboratories Inc (MLAB) News

MLAB Mesa Laboratories Inc

111,775
1,60 (1,45%)
Zuletzt aktualisiert: 19:39:53
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Mesa Laboratories Inc MLAB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
1,60 1,45% 111,775 19:39:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
111,59 108,97 112,40 110,18
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.4.202414:00GLOBEMESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND..
05.4.202400:24GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
01.4.202416:27GLOBEMesa Laboratories, Inc. to Announce Unaudited Fourth Quarter..
15.3.202412:00GLOBEMesa Labs Releases Second Annual Responsible Business..
16.2.202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202417:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.2.202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05.2.202414:00EDGAR2Form 8-K - Current report
05.2.202414:00GLOBEMesa Labs Announces Third Quarter Results
23.1.202420:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.1.202414:00EDGAR2Form 8-K - Current report
08.1.202414:00GLOBEMesa Laboratories Appoints Mark Capone to its Board of..
05.1.202415:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04.1.202421:00GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
03.1.202414:00GLOBEMesa Labs Completes the Acquisition of GKE Science &..
19.12.202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202316:21EDGAR2Form 144 - Report of proposed sale of securities
14.12.202316:47GLOBEMesa Laboratories, Inc. to Announce Second Quarter Results..
14.11.202312:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202314:00EDGAR2Form 8-K - Current report
06.11.202314:00GLOBEMesa Labs Announces Second Quarter Results
18.10.202319:26EDGAR2Form 8-K - Current report
16.10.202309:00GLOBEMesa Labs Acquires GKE-GmbH Complementary Sterilization..
10.10.202318:42EDGAR2Form 8-K - Current report
03.10.202314:00GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
19.9.202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202322:44EDGAR2Form 144 - Report of proposed sale of securities
13.9.202319:37GLOBEMesa Laboratories, Inc. to Announce Second Quarter Results..
06.9.202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202318:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202318:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202317:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.9.202318:45EDGAR2Form 144 - Report of proposed sale of securities
30.8.202321:31EDGAR2Form 8-K - Current report
30.8.202320:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
25.8.202322:32EDGAR2Form 8-K - Current report
24.8.202322:02GLOBEMesa Laboratories, Inc. Announces Commitment to Disclose..
16.8.202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202321:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202321:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202321:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202321:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
MLAB
Mesa Laboratories
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten